Novo Pakistan Steps Up to Support Insulin Access

Novo Pakistan is taking action to support individuals with diabetes in Pakistan, where an estimated 33 million people suffer from the condition and more than one million rely on insulin. The company is collaborating with partners to ensure a steady supply of insulin treatment, recognizing the critical importance of dependable access to insulin for those living with diabetes and their families.

Mehtaz Sultan Khan, General Manager of Novo Pakistan, emphasized that diabetes care has been central to Novo for over a century, and maintaining this commitment remains their top priority. Khan highlighted that reliable access to insulin treatment is essential for those depending on insulin and acknowledged the concerns surrounding the issue.

Novo Pakistan is committed to working with healthcare professionals, policymakers, and patient communities to enhance diabetes care in the country. Individuals with concerns about their prescribed insulin should consult a healthcare professional for appropriate next steps. They can also access educational resources, guidance, and connections to healthcare professionals through NovoCare. To seek information and support, visit NovoCare.pk or call 021-1111-46686.